p27(Kip1) is expressed transiently in developing myotomes and enhances myogenesis

Cell Growth and Differentiation

Volumn 9, Issue 1, 1998, Pages 1-11

  Zabludoff, Sonya D ^a,b   Csete, Marie ^a   Wagner, Roger ^a   Yu, Xin ^a   Wold, Barbara J ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; MYOD PROTEIN; MYOGENIN; PROTEIN P21; PROTEIN P27; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; EMBRYO; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; VERTEBRATE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MUSCLE; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MICROTUBULE-ASSOCIATED PROTEINS; MUSCLES; MYOD PROTEIN; PREGNANCY; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0031594780     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Olson, E. N. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154: 261-272, 1992
2. Lassar, A. B., Skapek, S. X., and Novitch, B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6: 788-794, 1994.
3. Clegg, C., Linkhart, T., Olwin, B., and Hauschka, S. Growth-factor control of skeletal-muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth-factor. J. Cell Biol. 105: 949-956, 1987.
4. Olson, E. N., Sternberg, W., Hu, J. S., Spizz, G., and Wilcox, C. Regulation of myogenic differentiation by type B transforming growth factor. J. Cell Biol. 103: 1799-1805, 1986.
5. Massaqué, J., Cheipetz, S., Endo, T. and Nadal-Ginard, B. Type B transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA, 83: 8206-8210, 1986.
6. Slingerland, J. M., Hengst. L., Pan, C. H., Alexander, D., Stampfer, M. R., and Reed, S. I. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor B-arrested epithelial cells. Mol. Cell. Biol. 14: 3683-3694, 1994.
7. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-depedent kinases. Cell, 75: 805-816, 1993.
8. Ohtsubo, M., and Roberts, J. M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science (Washington, DC), 259: 1908-1912, 1993.
9. 1, phase in rodent fibroblasts. Genes Dev., 7: 1559-1571, 1993.
10. Polyak, K., Kato, J-y., Solomon, M. J., Sherr, C. J., Massagué, J., Roberts, J. M., and Koff, A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 21: 9-22, 1994.
11. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
12. Toyoshima, H., and Hunter, T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
13. Sherr, C. J. Mammalian G(1) cyclins. Cell, 73: 1059-1065, 1993.
14. Sherr, C. J. D-type cyclins. Trends Biochem. Sci. 20:187-190, 1995.
15. Rao, S. S., Chu, C., and Kohtz, S. D. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14: 5259-5267, 1994.
16. Skapek, S. X., Rhee, J., Spicer, D. B., and Lassar, A. B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science (Washington DC), 267: 1022-1024, 1995.
17. Sherr, C. J. Cancer cell-cycles. Science (Washington DC), 274:1672-1677, 1996.
18. Sherr, C. J., and Roberts, J. M. Inhibitors of mammalian G(1) cyclin-dependent kinases. Genes Dev. 9: 1149-1163, 1995.
19. Molkentin, J. D., and Olson, E. N. Defining the regulatory networks for muscle development. Curr. Opin. Genet., 6: 445-453, 1996.
20. Yun, K. S., and Wold, B. J. Skeletal-muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8: 877-889, 1996.
21. Davis, R. L., Weintraub, H., and Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell, 57: 987-1000, 1987.
22. Braun, T., Buschhausen-Denker, G., Bober, E., Tannich, E., and Arnold, H. H. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J., 8: 701-709, 1989.
23. Wright, W. E., Sassoon, D. A., and Lin, V. K. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD1. Cell, 56: 607-617, 1989.
24. Edmondson, D. G., and Olson, E. N. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev., 3: 628-640, 1989.
25. Salminen, A., Braun, T., Buchberger, A., Jurs, S., Winter, B., and Arnold, H-H. Transcription of the muscle regulatory gene MYF4 is regulated by serum component, peptide growth factors and signaling pathways involving G proteins. J. Cell Biol., 115: 905-917, 1991.
26. Edmondson, D. G., Brennan, T. J., and Olson, E. N. Mitogenic repression of myogenin autoregulation. J. Biol. Chem. 266: 21343-21346, 1991.
27. Andres, V., and Walsh, K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol., 132: 657-666, 1996.
28. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., and Rhee, J. Correlation of terminal cell cycle arrest of skeletal muscle with induction of P21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
29. Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, W. J., and Elledge, S. J. p53-independent expression of p21cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
30. Novitch, B. G., Mulligan, G. J., Jacks, T., and Lassar, A. B. Skeletal-muscle cells lacking the retinoblastoma protein display defects in muscle gene-expression and accumulate in S-phases and G(2)-phases of the cell-cycle. J. Cell Biol., 135: 441-456, 1996.
31. Cossu, G., Kelly, R., Tajbakhsh, S., Didonna, S., Vivarelli, E., and Buckingham, M. Activation of different myogenic pathways: myf-5 is induced by the neural tube and myoD by the dorsal ectoderm in mouse paraxial mesoderm. Development (Camb.), 122: 429-437, 1996.
32. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell-cycle arrest of skeletal-muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
33. Pagano, M., Tam, S. W., Theodoras, A. M., Beerromero, P., Delsal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M. Role of the ubiquitinproteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995.
34. Hengst, L., and Reed, S. I. Translationsl control of p27kipl accumulation during the cell cycle. Science (Washington DC), 277: 1861-1864. 1996.
35. Koyama, H., Raines, E. W., Bornfeldt, K. E., Roberts, J. M., and Ross, R. Fibrillar collagen inhibits arterial smooth-muscle proliferation through regulation of cdk2 inhibitors. Cell, 87: 1069-1078, 1996.
36. Fera, M. L., et al. A syndrome of muttiorgan hyperplasia with features of gigantism, tumorgenesis, and female sterility in p27 kip -deficient mice. Cell, 35: 733-744, 1996.
37. Crescenzi, M., Fleming, T. P., Lassar, A. B., Weintraub, H., and Aaronson, S. A. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. USA, 87: 8442-8446, 1990.
38. Sorrentino, V., Pepperkok, R., Davis, R. L., Ansorge, W., and Philipson, L. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature (Lond.), 345: 813-815, 1990.
39. CIP Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 9: 650-662, 1995.
40. Smith, T. H., Kachinsky, A. M., and Miller, J. B. Somite subdomains, muscle cell origins, and the four muscle regulatory factor proteins. J. Cell Biol. 127:95-105, 1994.
41. Cossu, G., Tajbakhsh, S., and Buckingham, M. How is myogenesis initiated in the embryo? Trends Genet. 12: 218-223, 1996.
42. Franklin, D. S., and Xiong, Y. Induction of p18INK4c and its predominant association with cdk4 and cdk6 during myogenic differentiation. Mol. Biol. Cell, 7: 1587-1599, 1996.
43. Serrano, M., Lee, H. W., Chin, L. Cordoncardo, C., Beach, D., and Dephinho. R. A. Role of INK4A locus in tumor suppression and cell mortality. Cell, 85: 27-37, 1996.
44. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., and Nakayama, K. Mice lacking p27KIP1 display increased body size, multiple organ hyperplasia, retinal dysotasia, and pituitary tumors. Cell, 85: 707-720, 1996.
45. Kiyokawa. H., et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27KIP1. Cell, 85: 721-732, 1996.
46. Deng, C. X., Zhang, P. M., Harper, J. W., Elledge, S. J., and Leder, P. Mice lacking p21(CIP1/WAF1) undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675-684, 1995.
47. Skapek, S. X., Rhee. J., Kim, P. S., Novitch, B. G., and Lassar, A. B. Cyclin-mediated inhibition of muscle gene-expression via a mechanism that is independent of pRB hyperphosphorytaoon. Mol. Cell. Biol., 76: 7043-7053, 1996.
48. Novitch, B. G., Mulligan, G. J., Jacks, T., and Lassar, A. B. Sketetalmuscle cells lacking the retinoblastoma protein display defects in muscle gene-expression and accumulate in S-phases and G(2)-phases of the cell-cycle. J. Cell Biol., 135: 441-456, 1996.
49. Schneider, J. W., Gu, W., Zhu. L. Mahdavi, V., and Nadalginard, B. Reversal of terminal differentiation mediated by p107 in RB (-/-) muscle-cells. Science (Washington DC), 264: 1467-1471, 1994.
50. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadalginard, B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle-cell commitment and differentation. Cell, 72: 309-324, 1993.
51. Wang, J., and Walsh, K. Inhibition of retinoblastoma phosphorylation by myogenesis-induced changes in the subunit of the cyclin-dependent kinase 4 complex. Cell Growth Differ. 7: 1471-1478, 1996.
52. Quo, K., and Walsh, K. Inhibition of myogenesis by multiple cyclin-cdk complexes. J. Biol. Chem. 272: 791-797, 1997.
53. Li, L., Zhou, J., James, G., Heller-Hamson, R., Czech, M., and Olson, E. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DMA binding domains. Cell, 71: 1181-1194, 1992.
54. Li, L., Hellerharrison, R., Czech, M., and Olson, E. N. Cyclic AMP-dependent protein-kinase inhibits the activity of myogenic helix-loop-helix proteins. Mol. Cell. Biol. 12: 4478-4485, 1992.
55. Winter, B., Braun, T., and Arnold, H. H. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD. J. Biol. Chem., 268: 9869-9878, 1993.
56. Song, A., Wang, Q., Goebl, M. G., and Hamngton, M. A. The ubiquitin pathway is required for the rapid degradation of hyperphosphorylated MyoD. Mol. Biol. Cell, 7: 2075-2075, 1996.
57. Banerjee, A. C., Recupero, A. J., Mal, A., Piotrkowski, A. M., Wang. D. M., and Harter, M. L. The adenovirus E1A 289R and 243R proteins inhibit the phosphorylation of p300. Oncogene, 9: 1733-1737, 1994.
58. Ellis, L., Clauser, E., Morgan, D. O., Edery, M., Roth, R. A., and Rutter, W. J. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. 1986.
59. Johnson, J. E., Wold, B. J., and Hauschka, S. D. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol. Cell. Biol., 9: 3393-3399, 1989.
60. Gorman, C. M., Moffat, L. F., and Howard, B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1051, 1982.